Fennec Pharmaceuticals Inc. (FENC) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$7.3
Day's range
$8

Fennec Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ROSALIND ADVISORS, INC. 08/14/2026 3.19 M $34.27 M   9.62% 9.28%
AIGH CAPITAL MANAGEMENT LLC 08/07/2026 2.49 M $26.72 M   25.46% 7.24%
SOLAS CAPITAL MANAGEMENT, LLC 08/14/2026 1.89 M $20.31 M   -23.88% 5.50%
BLACKROCK, INC. 08/07/2026 1.73 M $18.57 M   26.23% 5.03%
AWM INVESTMENT COMPANY, INC. 08/14/2026 1.16 M $12.47 M   61.12% 3.38%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 839.31 K $9.02 M   -6.45% 2.44%
PROSPECT CAPITAL ADVISORS, LLC 08/14/2026 497.80 K $5.35 M   100.00% 1.45%
STATE STREET CORP 08/07/2026 426.00 K $4.58 M   18.65% 1.24%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 402.57 K $4.33 M   8.29% 1.17%
JANE STREET GROUP, LLC 08/14/2026 233.88 K $2.51 M   100.00% 0.68%
POTOMAC CAPITAL MANAGEMENT, INC. 08/14/2026 224.40 K $2.41 M   0.00% 0.65%
MORGAN STANLEY 08/13/2026 221.92 K $2.39 M   5.12% 0.65%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 200.00 K $2.15 M   18.71% 0.58%
NORTHERN TRUST CORP 08/13/2026 167.92 K $1.81 M   10.39% 0.49%
MARSHALL WACE, LLP 08/13/2026 138.76 K $1.49 M   100.00% 0.40%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 134.20 K $1.44 M   100.00% 0.39%
NUVEEN, LLC 08/11/2026 131.48 K $1.41 M   115.73% 0.38%
TREXQUANT INVESTMENT LP 08/14/2026 119.12 K $1.28 M   129.66% 0.35%
CENTERBOOK PARTNERS LP 08/11/2026 118.58 K $1.27 M   100.00% 0.35%
LION POINT CAPITAL, LP 08/14/2026 112.43 K $1.21 M   0.00% 0.33%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 108.01 K $1.16 M   30.12% 0.31%
CORNERSTONE CAPITAL, INC. 08/03/2026 105.00 K $1.13 M   0.00% 0.31%
XTX TOPCO LTD 08/14/2026 93.87 K $1.01 M   515.31% 0.27%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 92.89 K $998.56 K   284.70% 0.27%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 84.55 K $908.89 K   100.00% 0.25%
QUADRATURE CAPITAL LTD 08/07/2026 75.73 K $814.06 K   100.00% 0.22%
CITADEL ADVISORS LLC 08/14/2026 71.03 K $763.59 K   -53.76% 0.21%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 70.50 K $757.92 K   10.97% 0.21%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 70.50 K $757.92 K   100.00% 0.21%
1492 CAPITAL MANAGEMENT LLC 08/11/2026 65.15 K $700.35 K   28.49% 0.19%
BANK OF NEW YORK MELLON CORP 08/06/2026 61.03 K $656.10 K   16.34% 0.18%
TWO SIGMA INVESTMENTS, LP 08/14/2026 60.33 K $648.57 K   100.00% 0.18%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 58.29 K $626.64 K   98.42% 0.17%
THOMPSON SIEGEL & WALMSLEY LLC 08/11/2026 57.23 K $615.00 K   0.00% 0.17%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 56.41 K $606.38 K   100.00% 0.16%
ELEVA CAPITAL SAS 07/02/2026 53.23 K $327.39 K   0.00% 0.16%
HARTFORD FINANCIAL MANAGEMENT INC. 07/24/2026 50.65 K $544.45 K   0.00% 0.15%
ROUND ROCK ADVISORS, LLC 08/12/2026 48.68 K $523.34 K   100.00% 0.14%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 45.40 K $488.05 K   17.24% 0.13%
STATE OF WISCONSIN INVESTMENT BOARD 08/14/2026 38.61 K $415.00 K   -11.25% 0.11%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 36.73 K $394.82 K   492.66% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 35.20 K $378.40 K   57.14% 0.10%
RHUMBLINE ADVISERS 08/12/2026 34.97 K $375.91 K   11.73% 0.10%
GOLDMAN SACHS GROUP INC 08/14/2026 33.45 K $359.61 K   -39.90% 0.10%
SQUAREPOINT OPS LLC 08/14/2026 31.13 K $334.67 K   -44.91% 0.09%
PRELUDE CAPITAL MANAGEMENT, LLC 08/14/2026 29.60 K $318.19 K   0.00% 0.09%
DEUTSCHE BANK AG\ 08/07/2026 28.90 K $310.65 K   36.30% 0.08%
WELLS FARGO & COMPANY/MN 08/14/2026 26.56 K $285.56 K   143.77% 0.08%
MILLENNIUM MANAGEMENT LLC 08/14/2026 26.32 K $282.91 K   100.00% 0.08%
JONES FINANCIAL COMPANIES LLLP 08/14/2026 26.05 K $287.09 K   4.41% 0.08%

Fennec Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 131 institutional investors and hedge funds held shares of Fennec Pharmaceuticals Inc. The most heavily invested institutionals were:

Rosalind Advisors, Inc.: 3.19 M

AIGH Capital Management LLC: 2.49 M

Solas Capital Management, LLC: 1.89 M

BlackRock, Inc.: 1.73 M

AWM Investment Company, Inc.: 1.16 M

VANGUARD CAPITAL MANAGEMENT LLC: 839,306

47.73% of Fennec Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 24.47 M shares in the last 24 months. This purchase volume represents approximately $185.71 M in transactions.